WebMD Health Corporation (WBMD) In A Perilous Reversal
- WBMD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $36.0 million.
- WBMD has traded 2.1 million shares today.
- WBMD is down 5% today.
- WBMD was up 8.5% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in WBMD with the Ticky from Trade-Ideas. See the FREE profile for WBMD NOW at Trade-Ideas More details on WBMD: WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. Currently there are 2 analysts that rate WebMD Health Corporation a buy, 1 analyst rates it a sell, and 2 rate it a hold. The average volume for WebMD Health Corporation has been 930,300 shares per day over the past 30 days. WebMD Health has a market cap of $1.4 billion and is part of the technology sector and computer software & services industry. The stock has a beta of 1.23 and a short float of 14.6% with 5.04 days to cover. Shares are up 158.8% year to date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates WebMD Health Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Highlights from the ratings report include:
- WBMD's revenue growth has slightly outpaced the industry average of 9.4%. Since the same quarter one year prior, revenues rose by 11.4%. Growth in the company's revenue appears to have helped boost the earnings per share.
- Powered by its strong earnings growth of 200.00% and other important driving factors, this stock has surged by 147.64% over the past year, outperforming the rise in the S&P 500 Index during the same period. Although WBMD had significant growth over the past year, our hold rating indicates that we do not recommend additional investment in this stock at the current time.
- WEBMD HEALTH CORP reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, WEBMD HEALTH CORP swung to a loss, reporting -$0.44 versus $1.07 in the prior year. This year, the market expects an improvement in earnings ($0.25 versus -$0.44).
- Currently the debt-to-equity ratio of 1.86 is quite high overall and when compared to the industry average, suggesting that the current management of debt levels should be re-evaluated. Despite the company's weak debt-to-equity ratio, the company has managed to keep a very strong quick ratio of 5.96, which shows the ability to cover short-term cash needs.
- The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. Compared to other companies in the Internet Software & Services industry and the overall market, WEBMD HEALTH CORP's return on equity significantly trails that of both the industry average and the S&P 500.
- You can view the full WebMD Health Corporation Ratings Report.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.